國立虎尾科技大學 |

Gastric Cancer In The Precision Medicine Era = Diagnosis and Therapy /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Gastric Cancer In The Precision Medicine Era/ edited by Vincenzo Canzonieri, Antonio Giordano.
Reminder of title:	Diagnosis and Therapy /
other author:	Canzonieri, Vincenzo.
Description:	XV, 256 p. 47 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pathology. -
Online resource:	https://doi.org/10.1007/978-3-030-04861-7
ISBN:	9783030048617

Gastric Cancer In The Precision Medicine Era = Diagnosis and Therapy /
Gastric Cancer In The Precision Medicine EraDiagnosis and Therapy /[electronic resource] :edited by Vincenzo Canzonieri, Antonio Giordano. - 1st ed. 2019. - XV, 256 p. 47 illus. in color.online resource. - Current Clinical Pathology,2197-781X. - Current Clinical Pathology,.

Gastric Tumorigenesis: Role of Inflammation and Helicobacter Pylori -- Genetic and Epigenetic Mechanisms in Gastric Cancer -- Diagnosis and Surveillance: Endoscopic Hallmarks -- Pathological Diagnosis And Classification Of Gastric Epithelial Tumors -- Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer -- Serum Biomarkers in Gastric Cancer -- New Agents in the treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapy -- Combined-Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives -- Surgical Strategies in Gastric Cancer -- From Molecular Classification to Targeted Therapy for Gastric Cancer in the Precision Medicine Era -- Non-Coding RNA in Gastric Cancer with Potential Prognostic and Predictive Role -- Immunomodulation and Immunotherapy for Gastric Cancer -- Nanomedicine in Gastric Cancer.

This book provides a comprehensive, state-of-the art review and serves as an overview of the different aspects of gastric cancer. The first section aims to clarify the main aspects of tumorigenesis, such as the role of inflammation linked to the presence of H. Pylori infection, and the genetic and epigenetic mechanisms so far known. Secondly, an exhaustive overview of the diagnosis of gastric cancer from a clinical/endoscopic and pathologic perspective will be illustrated. The second section includes the pathological and clinical features and contains information regarding the most recent tissue and serological biomarkers in these neoplasms. The three successive sections are intended to provide the “state of art” of multimodal treatment approaches to gastric cancer, i.e. standard and novel surgical aspects, common and innovative chemo and radio protocols and modern targeted therapies. Novel molecular classifications are under consideration to improve diagnostic and prognostic definitions and to prospect future treatments based on the use of immunotherapies and innovative molecules such as non-coding RNA and nanoparticles. Gastric Cancer in the Precision Medicine Era serves as a useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy. It provides a concise yet comprehensive summary of the current status of the field that helps guide patient management and stimulates investigative efforts. All chapters are written by experts in their fields and includes the most up to date scientific and clinical information.

ISBN: 9783030048617

Standard No.: 10.1007/978-3-030-04861-7doiSubjects--Topical Terms:

668553
Pathology.

LC Class. No.: RB1-214

Dewey Class. No.: 616.07

Gastric Cancer In The Precision Medicine Era = Diagnosis and Therapy /
LDR:03844nam a22003975i 4500 001 1012703
003 DE-He213
005 20200706111414.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030048617 $9 978-3-030-04861-7
024 7 $a 10.1007/978-3-030-04861-7 $2 doi
035 $a 978-3-030-04861-7
050 4 $a RB1-214
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.07 $2 23
245 1 0 $a Gastric Cancer In The Precision Medicine Era $h [electronic resource] : $b Diagnosis and Therapy / $c edited by Vincenzo Canzonieri, Antonio Giordano.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Humana, $c 2019.
300 $a XV, 256 p. 47 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Clinical Pathology, $x 2197-781X
505 0 $a Gastric Tumorigenesis: Role of Inflammation and Helicobacter Pylori -- Genetic and Epigenetic Mechanisms in Gastric Cancer -- Diagnosis and Surveillance: Endoscopic Hallmarks -- Pathological Diagnosis And Classification Of Gastric Epithelial Tumors -- Diagnostic, Prognostic, Predictive and Therapeutic Tissue Biomarkers in Gastric Cancer -- Serum Biomarkers in Gastric Cancer -- New Agents in the treatment of Advanced Gastric Cancer: Targeted Therapy and Immunotherapy -- Combined-Modality Treatment for Locally Advanced Gastric Cancer: Current Evidences and New Perspectives -- Surgical Strategies in Gastric Cancer -- From Molecular Classification to Targeted Therapy for Gastric Cancer in the Precision Medicine Era -- Non-Coding RNA in Gastric Cancer with Potential Prognostic and Predictive Role -- Immunomodulation and Immunotherapy for Gastric Cancer -- Nanomedicine in Gastric Cancer.
520 $a This book provides a comprehensive, state-of-the art review and serves as an overview of the different aspects of gastric cancer. The first section aims to clarify the main aspects of tumorigenesis, such as the role of inflammation linked to the presence of H. Pylori infection, and the genetic and epigenetic mechanisms so far known. Secondly, an exhaustive overview of the diagnosis of gastric cancer from a clinical/endoscopic and pathologic perspective will be illustrated. The second section includes the pathological and clinical features and contains information regarding the most recent tissue and serological biomarkers in these neoplasms. The three successive sections are intended to provide the “state of art” of multimodal treatment approaches to gastric cancer, i.e. standard and novel surgical aspects, common and innovative chemo and radio protocols and modern targeted therapies. Novel molecular classifications are under consideration to improve diagnostic and prognostic definitions and to prospect future treatments based on the use of immunotherapies and innovative molecules such as non-coding RNA and nanoparticles. Gastric Cancer in the Precision Medicine Era serves as a useful resource for physicians and researchers dealing with, and interested in, this challenging malignancy. It provides a concise yet comprehensive summary of the current status of the field that helps guide patient management and stimulates investigative efforts. All chapters are written by experts in their fields and includes the most up to date scientific and clinical information.
650 0 $a Pathology. $3 668553
650 0 $a Gastroenterology . $3 1254565
650 0 $a Surgery. $3 644132
650 0 $a Oncology . $3 1253469
650 2 4 $a Gastroenterology. $3 673684
650 2 4 $a General Surgery. $3 673829
650 2 4 $a Oncology. $3 593951
700 1 $a Canzonieri, Vincenzo. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1306968
700 1 $a Giordano, Antonio. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1110704
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030048600
776 0 8 $i Printed edition: $z 9783030048624
830 0 $a Current Clinical Pathology, $x 2197-781X $3 1254599
856 4 0 $u https://doi.org/10.1007/978-3-030-04861-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)